175 related articles for article (PubMed ID: 27827420)
41. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
42. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
[TBL] [Abstract][Full Text] [Related]
43. MITF, the Janus transcription factor of melanoma.
Koludrovic D; Davidson I
Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
[TBL] [Abstract][Full Text] [Related]
44. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells.
Jian D; Jiang D; Su J; Chen W; Hu X; Kuang Y; Xie H; Li J; Chen X
Steroids; 2011 Nov; 76(12):1297-304. PubMed ID: 21745488
[TBL] [Abstract][Full Text] [Related]
45. Cilostazol promotes production of melanin by activating the microphthalmia-associated transcription factor (MITF).
Wei B; Zhang YP; Yan HZ; Xu Y; Du TM
Biochem Biophys Res Commun; 2014 Jan; 443(2):617-21. PubMed ID: 24333333
[TBL] [Abstract][Full Text] [Related]
46. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
47. Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.
Noguchi S; Kumazaki M; Mori T; Baba K; Okuda M; Mizuno T; Akao Y
Vet Comp Oncol; 2016 Dec; 14(4):384-394. PubMed ID: 25280339
[TBL] [Abstract][Full Text] [Related]
48. MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1.
Liu F; Fu Y; Meyskens FL
J Invest Dermatol; 2009 Feb; 129(2):422-31. PubMed ID: 18971960
[TBL] [Abstract][Full Text] [Related]
49. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
50. The MITF family of transcription factors: Role in endolysosomal biogenesis, Wnt signaling, and oncogenesis.
Ploper D; De Robertis EM
Pharmacol Res; 2015 Sep; 99():36-43. PubMed ID: 26003288
[TBL] [Abstract][Full Text] [Related]
51. Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
Ugurel S; Houben R; Schrama D; Voigt H; Zapatka M; Schadendorf D; Bröcker EB; Becker JC
Clin Cancer Res; 2007 Nov; 13(21):6344-50. PubMed ID: 17975146
[TBL] [Abstract][Full Text] [Related]
52. P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition.
Najem A; Krayem M; Salès F; Hussein N; Badran B; Robert C; Awada A; Journe F; Ghanem GE
Eur J Cancer; 2017 Sep; 83():154-165. PubMed ID: 28738256
[TBL] [Abstract][Full Text] [Related]
53. Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells.
Motzik A; Amir E; Erlich T; Wang J; Kim BG; Han JM; Kim JH; Nechushtan H; Guo M; Razin E; Tshori S
Oncogene; 2017 Aug; 36(33):4732-4738. PubMed ID: 28394346
[TBL] [Abstract][Full Text] [Related]
54. Novel MITF targets identified using a two-step DNA microarray strategy.
Hoek KS; Schlegel NC; Eichhoff OM; Widmer DS; Praetorius C; Einarsson SO; Valgeirsdottir S; Bergsteinsdottir K; Schepsky A; Dummer R; Steingrimsson E
Pigment Cell Melanoma Res; 2008 Dec; 21(6):665-76. PubMed ID: 19067971
[TBL] [Abstract][Full Text] [Related]
55. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.
Sestáková B; Ondrusová L; Vachtenheim J
Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556
[TBL] [Abstract][Full Text] [Related]
56. c-Met is a potentially new therapeutic target for treatment of human melanoma.
Puri N; Ahmed S; Janamanchi V; Tretiakova M; Zumba O; Krausz T; Jagadeeswaran R; Salgia R
Clin Cancer Res; 2007 Apr; 13(7):2246-53. PubMed ID: 17404109
[TBL] [Abstract][Full Text] [Related]
57. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
[TBL] [Abstract][Full Text] [Related]
58. Altered expression of the iron transporter Nramp1 (Slc11a1) during fetal development of the retinal pigment epithelium in microphthalmia-associated transcription factor Mitf(mi) and Mitf(vitiligo) mouse mutants.
Gelineau-van Waes J; Smith L; van Waes M; Wilberding J; Eudy JD; Bauer LK; Maddox J
Exp Eye Res; 2008 Feb; 86(2):419-33. PubMed ID: 18191835
[TBL] [Abstract][Full Text] [Related]
59. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
Snyder ER; Ricker JL; Chen Z; Waes CV
Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
[TBL] [Abstract][Full Text] [Related]
60. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
Primot A; Mogha A; Corre S; Roberts K; Debbache J; Adamski H; Dreno B; Khammari A; Lesimple T; Mereau A; Goding CR; Galibert MD
Pigment Cell Melanoma Res; 2010 Feb; 23(1):93-102. PubMed ID: 19895547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]